How Could Anyone Sell ONCS Below $0.50 Given Brian Nichols' Interview of Management?
Take 5 minutes and read! This company is loaded with catalysts on programs that we already expect (melanoma/MCC), but is planning to combine electroporation (already proven effective via ONCS/INO) with the most effective agents in immuno-oncology (anti-PD1s).
Not to mention, MCC data will be coming out soon, and if positive, and immune responses continue, we'll be talking about accelerated approval, maybe Breakthrough designations by the end of year. ONCS will be over $2